Search Results - "Stempak, J"

Refine Results
  1. 1
  2. 2

    MAST3: a novel IBD risk factor that modulates TLR4 signaling by Labbé, C, Goyette, P, Lefebvre, C, Stevens, C, Green, T, Tello-Ruiz, M K, Cao, Z, Landry, A L, Stempak, J, Annese, V, Latiano, A, Brant, S R, Duerr, R H, Taylor, K D, Cho, J H, Steinhart, A H, Daly, M J, Silverberg, M S, Xavier, R J, Rioux, J D

    Published in Genes and immunity (01-10-2008)
    “…Inflammatory bowel disease (IBD) is a chronic disorder caused by multiple factors in a genetically susceptible host. Significant advances in the study of…”
    Get full text
    Journal Article
  3. 3

    The effect of dietary folate on genomic and p53-specific DNA methylation in rat colon by Sohn, Kyoung-Jin, Stempak, Joanne M., Reid, Sarah, Shirwadkar, Shaila, Mason, Joel B., Kim, Young-In

    Published in Carcinogenesis (New York) (01-01-2003)
    “…Folate is an important mediator in the transfer of methyl groups for DNA methylation, abnormalities of which are considered to play an important mechanistic…”
    Get full text
    Journal Article
  4. 4

    P468 Relevance of anti-drug antibodies in context of supra-therapeutic anti-TNF concentrations by Kim, J, Walshe, M, Borowski, K, Milgrom, R, Stempak, J, Lee, S H, Croitoru, K, Silverberg, M S

    Published in Journal of Crohn's and colitis (24-01-2024)
    “…Abstract Background The low serum concentration of anti-tumor necrosis factor-alpha (anti-TNFα) agents and the presence of anti-drug antibodies are related to…”
    Get full text
    Journal Article
  5. 5

    Magnesium Dietary Intake Modulates Blood Lipid Levels and Atherogenesis by Altura, Bella T., Brust, Manfred, Bloom, Sherman, Barbour, Randall L., Stempak, Jerome G., Altura, Burton M.

    “…In this study, we have examined the effects of variation in dietary Mg on the atherogenic process. Oral supplementation of rabbits fed a high cholesterol diet…”
    Get full text
    Journal Article
  6. 6

    P708 Ileal involvement defined by Montreal classification in Crohn’s disease is associated with a distinct microbial composition in ileal and colonic mucosa by Hernandez-Rocha, C, Nayeri, S, Turpin, W, Borowski, K, Stempak, J, Silverberg, M S

    Published in Journal of Crohn's and colitis (21-01-2022)
    “…Abstract Background The Montreal classification of inflammatory bowel disease (IBD) recognizes distinct subgroups based on location of disease, age at onset…”
    Get full text
    Journal Article
  7. 7

    DOP06 Histologic activity in Ulcerative Colitis patients achieving endoscopic healing is associated with higher rate of relapse and a distinct mucosal microbial and transcriptional profile by Hernandez-Rocha, C, Turpin, W, Nayeri, S, Borowski, K, Stempak, J, Conner, J, Silverberg, M S

    Published in Journal of Crohn's and colitis (27-05-2021)
    “…Abstract Background Histologic remission (HR) in ulcerative colitis (UC) has been associated with better clinical outcomes. However, this therapeutic target is…”
    Get full text
    Journal Article
  8. 8

    Protein Zero, a Nervous System Adhesion Molecule, Triggers Epithelial Reversion in Host Carcinoma Cells by Doyle, Joseph P., Stempak, Jerome G., Cowin, Pamela, Colman, David R., D'Urso, Donatella

    Published in The Journal of cell biology (01-10-1995)
    “…Protein zero ( P o) is the immunoglobulin gene superfamily glycoprotein that mediates the self-adhesion of the Schwann cell plasma membrane that yields compact…”
    Get full text
    Journal Article
  9. 9
  10. 10

    A181 HIGHER CUMULATIVE HISTOLOGIC INFLAMMATORY BURDEN SCORE IS ASSOCIATED WITH THE RISK OF DEVELOPMENT OF COLORECTAL NEOPLASIA IN ULCERATIVE COLITIS by Graff, D, Hernandez-Rocha, C, Borowski, K, Stempak, J, Conner, J, Silverberg, M S

    “…Abstract Background Ulcerative colitis (UC) patients have an elevated risk of colorectal neoplasia (CRN). Younger age at diagnosis, extent of colitis, and…”
    Get full text
    Journal Article
  11. 11
  12. 12

    A88 A PROSPECTIVE STUDY OF MECHANISMS OF INTESTINAL INFLAMMATION AFTER ILEAL RESECTION IN CROHN’S DISEASE: PRELIMINARY ANALYSIS OF PHENOTYPIC PREDICTORS OF ENDOSCOPIC RECURRENCE by Boland, K, Stempak, J, Silverberg, M S

    “…Abstract Background Post-operative endoscopic recurrence of ileal Crohn’s Disease (CD) is common, however the evolution of disease recurrence over time…”
    Get full text
    Journal Article
  13. 13
  14. 14

    A26 USE OF DRUG-TOLERANT ASSAYS IN INFLAMMATORY BOWEL DISEASE; WHAT DOES IT TELL US? by Walshe, M, Borowski, K, Stempak, J, Silverberg, M S

    “…Abstract Background Therapeutic drug monitoring helps guide decision making in the treatment of IBD with anti-TNF therapies. Unlike older assays, newer…”
    Get full text
    Journal Article
  15. 15

    Protein zero of peripheral nerve myelin: biosynthesis, membrane insertion, and evidence for homotypic interaction by D'Urso, D, Brophy, P J, Staugaitis, S M, Gillespie, C S, Frey, A B, Stempak, J G, Colman, D R

    Published in Neuron (Cambridge, Mass.) (01-03-1990)
    “…Protein zero (P0), an integral membrane glycoprotein synthesized by Schwann cells, is the major glycoprotein of peripheral nerve myelin. The predicted…”
    Get more information
    Journal Article
  16. 16

    A101 USTEKINUMAB LEVELS MEASURED DURING INDUCTION ARE ASSOCIATED WITH CLINICAL AND BIOCHEMICAL OUTCOMES AT WEEK 12 OF TREATMENT IN CROHN’S DISEASE by Walshe, M, Borowski, K, Boland, K, Rho, S, Stempak, J, Silverberg, M

    “…Abstract Background Therapeutic drug monitoring (TDM) helps guide use of anti-TNF drugs in IBD patients. In addition, higher anti-TNF levels during induction…”
    Get full text
    Journal Article
  17. 17

    A9 BACTERIAL BILE SALT HYDROLASE GENE ABUNDANCE IS ASSOCIATED WITH RORC GENE EXPRESSION IN INTESTINAL MUCOSA OF INFLAMMATORY DISEASE PATIENTS by Hernandez-Rocha, C, Borowski, K, Turpin, W, Smith, M, Stempak, J, Silverberg, M S

    “…Abstract Background The role of gut microbes involved in bile acid metabolism and their impact on mucosal immune regulation is beginning to be appreciated. For…”
    Get full text
    Journal Article
  18. 18

    A41 LOSS OF SATB2 EXPRESSION IN COLORECTAL CANCER IS ASSOCIATED WITH DURATION OF INFLAMMATORY BOWEL DISEASE by Atin, J, Hernandez-Rocha, C, Borowski, K, Stempak, J, Smith, M, Conner, J R, Silverberg, M

    “…Abstract Background Patients with inflammatory bowel disease (IBD) are at higher risk for developing colitis-associated colorectal cancer (CAC). Clinical and…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Conducting Translational Gastrointestinal Research in the Era of COVID-19 by Nayeri, Shadi, Walshe, Margaret, Lee, Sun-Ho, Filice, Melissa, Rho, Stella, Jeyakumar, Ajani, Stempak, Joanne, Smith, Michelle I, Silverberg, Mark S

    Published in Journal of Crohn's and colitis (02-12-2020)
    “…Abstract Spread of the novel coronavirus SARS-CoV-2 has resulted in a global pandemic that is affecting the health and economy of all World Health Organization…”
    Get full text
    Journal Article